January 28, 2012
/EIN Presswire/ -- Prostatehealthanswers.com was launched by MediCom Worldwide, Inc., a leading medical education company, to deal with mens' urological health issues. The site features questions and answers to issues most frequently dealt with by men battling
prostatecancer and other urological issues in an easy-to-use video format.
MediCom Worldwide, Inc., a leading medical education company, announced today the launch of a new website to deal with mens' urological issues, including prostate health. The site is known as
Prostate Health Answers, and features questions and answers to issues most frequently dealt with by men battling prostate cancer and other urological issues in an easy-to-use video format.
The first Prostate Health Answers topic deals with concerns related to prostate health. Known experts in the field, such as
Dan Zenka with the Prostate
Cancer Foundation and Donald "Skip" Trump, MD, from Roswell Park Cancer Institute, are featured. Examples of some of the questions answered on the site are:
- Isn't prostate cancer an old man's disease?
- I've heard that men are likely to die with prostate cancer than from it. Is that true?
- Why is there so much confusion around PSA screening?
In addition, the site has a robust clinical trial search feature that allows visitors to look for available research studies seeking participants. Additional topics are scheduled for release throughout the year.
For more information, please visit
www.ProstateHealthAnswers.com.
About MediCom Worldwide, Inc.
MediCom Worldwide, Inc. remains a leading provider of continuing education activities for medical professionals today, specializing in creating dynamic interactive programs. Although the Foundation will be a separate 501c3 non-profit organization, it will benefit from MediCom's expertise and experience and will support education efforts in the Bucks County community.
Media Contact:
Joan Meyer
MediCom Worldwide, Inc.
215-337-9991
http://www.prostatehealthanswers.com# # #
Read more Press Releases by EIN Presswire: